SlideShare a Scribd company logo
FGF23 LEVELS RAISE SIGNIFICANTLY IN FEMALE HIP
FRACTURE PATIENTS WITH POSTOPERATIVE AKI
Sakan S, Bandic Pavlovic D, Basic-Jukic N, Kes P, Magas Vadlja J, Tonkovic D
Department of Anesthesiology and Intensive care, Jordanovac Clinical Department of Thoracic surgery,
Zagreb University Hospital Center,Jordanovac 104, Zagreb, Croatia
1.Goebel et al. J Orthop Res 2009;
27:1141-1146; Christov et al. Kidney
International 2013; 84:776-785.
Wang WJ et al. J Bone Miner Res
2104; 29.676-684
References
Postoperative AKI
-commom complication in hip fracture surgery
-female geneder independent predictor
-AKI incidence varies between 9% and 24%
- associated with higher postoperative
morbidity, mortality, longer hospital stay and
treatment costs
-FGF23 novel, early, renal biomarker of AKI
HYPOTHESIS
FGF23 is a novel, early renal biomarker of postoperative AKI
in female hip fracture patients
A pilot prospective cohort study during one month period
Inclusion criteria: female gender, trauma hip fracture
surgery, semi-scheduled surgery, age >18 years
Study included two groups:
1) AKI group N=9
- female subjects who developed AKI 24 h after operation
according to RIFLE/AKIN criteria
2) Control group N=7
- female subjects with normal renal function 24h after
operation
STUDY PROTOCOL
AKI group- plasma FGF23, serum creatinine, phosphate i
calcium measurements 24h after operation
Control group- plasma FGF23 and serum creatinine
measurement 24h after operation
Introduction1
Methods2
Results3
AKI group FGF 23 levels were 39 times higher than
control group (2352 vs 61 RU/ml). Hypocalcemia
(median (IQR) 1,9 (1,70-2,01) mmol/l) and
normophosphatemia (median (IQR) 0,89 (0,56-1,51)
mmol/l) were recorded in the AKI group. Serum
creatinine showed the same pattern of changes as
FGF23 but not such large increase ( 354 vs 67 μmol/l)
4
Conclusion
Female AKI group Control group
N 9 7
Age* 80 (75-82) 75 (68-79)
Baseline serum
creatinine
μmol/l*
78 (70-82) 99 (82-107)
0
200
400
600
800
AKI group Control
group
FGF23
FGF23
0
50
100
150
200
AKI
group
Control
group
Creatinine
Creatinine
Postoperative FGF23 levels showed
significantly high and rapid elevation in
AKI female hip fracture group.
Female AKI group Control group
Sepsis 1 0
Length of the
ICU stay (days)
6 (1,5-20) 2 (2-3)
Length of post
ICU stay (days)
9 (4-27) 10 (8-13)
Hospital
mortality
1 0
Postoperative
complications
1 0
Table 1
Figure 1
Figure 2 Figure 3
Table 2
0 1 2
3
Arterial hypertension
Diabetes mellitus
Cardiovascular
Pulmonary
N
N
*Median (IQR)
*Median (IQR)
39x 5.3x

More Related Content

What's hot

Electrolytes & Acid-Base Disturbance Workshop - Dr. Gawad
Electrolytes & Acid-Base Disturbance Workshop - Dr. GawadElectrolytes & Acid-Base Disturbance Workshop - Dr. Gawad
Electrolytes & Acid-Base Disturbance Workshop - Dr. Gawad
NephroTube - Dr.Gawad
 
Fatores de risco iu pós prostatectomia
Fatores de risco iu pós prostatectomiaFatores de risco iu pós prostatectomia
Fatores de risco iu pós prostatectomia
claudiahacad
 
Factors Predict Perioperative Morbidity pancreatic resection
Factors Predict Perioperative Morbidity pancreatic resectionFactors Predict Perioperative Morbidity pancreatic resection
Factors Predict Perioperative Morbidity pancreatic resection
Oncocir (Unidad de Oncología Quirúrgica)
 
Everything you need to know about moa of bone targeted agents amgen 2017
Everything you need to know about moa of bone targeted agents amgen 2017Everything you need to know about moa of bone targeted agents amgen 2017
Everything you need to know about moa of bone targeted agents amgen 2017
Mohamed Abdulla
 
Dr. Goy MCL
Dr. Goy MCLDr. Goy MCL
Management of metastatic colorectal cancer
Management of metastatic colorectal cancerManagement of metastatic colorectal cancer
Management of metastatic colorectal cancer
Mohamed Abdulla
 
Obesity in CKD and Renal Transplantation 2017
Obesity in CKD and Renal Transplantation 2017Obesity in CKD and Renal Transplantation 2017
Obesity in CKD and Renal Transplantation 2017
Meguid Nahas
 
Controversies in Colorectal Cancer
Controversies in Colorectal CancerControversies in Colorectal Cancer
Controversies in Colorectal Cancer
spa718
 
cystatin C as an early marker of cisplatin-induced AKI
cystatin C as an early marker of cisplatin-induced AKIcystatin C as an early marker of cisplatin-induced AKI
cystatin C as an early marker of cisplatin-induced AKI
د.محمود نجيب
 
Liver transplantation an update
Liver transplantation an updateLiver transplantation an update
Liver transplantation an update
mostafa hegazy
 
Ohio State's ASH Review 2017 - Benign Hematology
Ohio State's ASH Review 2017 - Benign HematologyOhio State's ASH Review 2017 - Benign Hematology
Ohio State's ASH Review 2017 - Benign Hematology
OSUCCC - James
 
Adipocytes and stem cell engraftment
Adipocytes and stem cell engraftmentAdipocytes and stem cell engraftment
Adipocytes and stem cell engraftment
spa718
 
Liver stiffness measurement (fibroscan®)
Liver stiffness measurement (fibroscan®)Liver stiffness measurement (fibroscan®)
Liver stiffness measurement (fibroscan®)
Samir Haffar
 
FT SURGERY IN SPAIN: ON THE WAY TO IMPLEMENTATION?
FT SURGERY IN SPAIN:  ON THE WAY TO IMPLEMENTATION?FT SURGERY IN SPAIN:  ON THE WAY TO IMPLEMENTATION?
FT SURGERY IN SPAIN: ON THE WAY TO IMPLEMENTATION?
fast.track
 
Weight loss surgery safe & effective
Weight loss surgery   safe & effectiveWeight loss surgery   safe & effective
Weight loss surgery safe & effective
foregutsurgeon
 
Clinical Impact of New NAFLD/NASH Data From EASL 2018
Clinical Impact of New NAFLD/NASH Data From EASL 2018Clinical Impact of New NAFLD/NASH Data From EASL 2018
Clinical Impact of New NAFLD/NASH Data From EASL 2018
hivlifeinfo
 
Evolution transfusion in a general hospital. Dr García Erce. NATA 2016
Evolution transfusion in a general hospital. Dr García Erce. NATA 2016Evolution transfusion in a general hospital. Dr García Erce. NATA 2016
Evolution transfusion in a general hospital. Dr García Erce. NATA 2016
José Antonio García Erce
 
Iron and cancer talk k m mohandas
Iron and cancer talk k m mohandasIron and cancer talk k m mohandas
Iron and cancer talk k m mohandas
Sanjeev Kumar
 
Personalized medicine in prostate cancer care
Personalized medicine in prostate cancer carePersonalized medicine in prostate cancer care
Personalized medicine in prostate cancer care
Europa Uomo EPAD
 
Drug Development in Nash Cirrhosis by Dr. Peter G. Traber, Sept 2019
Drug Development in Nash Cirrhosis by Dr. Peter G. Traber, Sept 2019Drug Development in Nash Cirrhosis by Dr. Peter G. Traber, Sept 2019
Drug Development in Nash Cirrhosis by Dr. Peter G. Traber, Sept 2019
Alacrita Life Science Consulting
 

What's hot (20)

Electrolytes & Acid-Base Disturbance Workshop - Dr. Gawad
Electrolytes & Acid-Base Disturbance Workshop - Dr. GawadElectrolytes & Acid-Base Disturbance Workshop - Dr. Gawad
Electrolytes & Acid-Base Disturbance Workshop - Dr. Gawad
 
Fatores de risco iu pós prostatectomia
Fatores de risco iu pós prostatectomiaFatores de risco iu pós prostatectomia
Fatores de risco iu pós prostatectomia
 
Factors Predict Perioperative Morbidity pancreatic resection
Factors Predict Perioperative Morbidity pancreatic resectionFactors Predict Perioperative Morbidity pancreatic resection
Factors Predict Perioperative Morbidity pancreatic resection
 
Everything you need to know about moa of bone targeted agents amgen 2017
Everything you need to know about moa of bone targeted agents amgen 2017Everything you need to know about moa of bone targeted agents amgen 2017
Everything you need to know about moa of bone targeted agents amgen 2017
 
Dr. Goy MCL
Dr. Goy MCLDr. Goy MCL
Dr. Goy MCL
 
Management of metastatic colorectal cancer
Management of metastatic colorectal cancerManagement of metastatic colorectal cancer
Management of metastatic colorectal cancer
 
Obesity in CKD and Renal Transplantation 2017
Obesity in CKD and Renal Transplantation 2017Obesity in CKD and Renal Transplantation 2017
Obesity in CKD and Renal Transplantation 2017
 
Controversies in Colorectal Cancer
Controversies in Colorectal CancerControversies in Colorectal Cancer
Controversies in Colorectal Cancer
 
cystatin C as an early marker of cisplatin-induced AKI
cystatin C as an early marker of cisplatin-induced AKIcystatin C as an early marker of cisplatin-induced AKI
cystatin C as an early marker of cisplatin-induced AKI
 
Liver transplantation an update
Liver transplantation an updateLiver transplantation an update
Liver transplantation an update
 
Ohio State's ASH Review 2017 - Benign Hematology
Ohio State's ASH Review 2017 - Benign HematologyOhio State's ASH Review 2017 - Benign Hematology
Ohio State's ASH Review 2017 - Benign Hematology
 
Adipocytes and stem cell engraftment
Adipocytes and stem cell engraftmentAdipocytes and stem cell engraftment
Adipocytes and stem cell engraftment
 
Liver stiffness measurement (fibroscan®)
Liver stiffness measurement (fibroscan®)Liver stiffness measurement (fibroscan®)
Liver stiffness measurement (fibroscan®)
 
FT SURGERY IN SPAIN: ON THE WAY TO IMPLEMENTATION?
FT SURGERY IN SPAIN:  ON THE WAY TO IMPLEMENTATION?FT SURGERY IN SPAIN:  ON THE WAY TO IMPLEMENTATION?
FT SURGERY IN SPAIN: ON THE WAY TO IMPLEMENTATION?
 
Weight loss surgery safe & effective
Weight loss surgery   safe & effectiveWeight loss surgery   safe & effective
Weight loss surgery safe & effective
 
Clinical Impact of New NAFLD/NASH Data From EASL 2018
Clinical Impact of New NAFLD/NASH Data From EASL 2018Clinical Impact of New NAFLD/NASH Data From EASL 2018
Clinical Impact of New NAFLD/NASH Data From EASL 2018
 
Evolution transfusion in a general hospital. Dr García Erce. NATA 2016
Evolution transfusion in a general hospital. Dr García Erce. NATA 2016Evolution transfusion in a general hospital. Dr García Erce. NATA 2016
Evolution transfusion in a general hospital. Dr García Erce. NATA 2016
 
Iron and cancer talk k m mohandas
Iron and cancer talk k m mohandasIron and cancer talk k m mohandas
Iron and cancer talk k m mohandas
 
Personalized medicine in prostate cancer care
Personalized medicine in prostate cancer carePersonalized medicine in prostate cancer care
Personalized medicine in prostate cancer care
 
Drug Development in Nash Cirrhosis by Dr. Peter G. Traber, Sept 2019
Drug Development in Nash Cirrhosis by Dr. Peter G. Traber, Sept 2019Drug Development in Nash Cirrhosis by Dr. Peter G. Traber, Sept 2019
Drug Development in Nash Cirrhosis by Dr. Peter G. Traber, Sept 2019
 

Similar to FGF23 levels raise significantly in female hip fracture patients with postoperative AKI

Journal Club Presentation
Journal Club PresentationJournal Club Presentation
Journal Club Presentation
Anand Reddy
 
NOAC-Midyear Poster (final)
NOAC-Midyear Poster (final)NOAC-Midyear Poster (final)
NOAC-Midyear Poster (final)
KwanNok Leung
 
Spark classification
Spark classificationSpark classification
Spark classification
Dr. Prem Mohan Jha
 
09 Nouri Acute Renal Failure
09 Nouri   Acute Renal Failure09 Nouri   Acute Renal Failure
09 Nouri Acute Renal Failure
guest2379201
 
09 Nouri Acute Renal Failure
09 Nouri   Acute Renal Failure09 Nouri   Acute Renal Failure
09 Nouri Acute Renal Failure
Dang Thanh Tuan
 
Utilizing Doppler Flow to Investigate the Hemodynamic Effects of Anti-Cancer ...
Utilizing Doppler Flow to Investigate the Hemodynamic Effects of Anti-Cancer ...Utilizing Doppler Flow to Investigate the Hemodynamic Effects of Anti-Cancer ...
Utilizing Doppler Flow to Investigate the Hemodynamic Effects of Anti-Cancer ...
Scintica Instrumentation
 
CRRT Principles (Thai).pdf
CRRT Principles (Thai).pdfCRRT Principles (Thai).pdf
CRRT Principles (Thai).pdf
justlim
 
ROLE OF ECHOGRAPHY AND COMPUTED TOMOGRAPHY IN DIAGNOSIS OF CHRONIC DIFFUSE LI...
ROLE OF ECHOGRAPHY AND COMPUTED TOMOGRAPHY IN DIAGNOSIS OF CHRONIC DIFFUSE LI...ROLE OF ECHOGRAPHY AND COMPUTED TOMOGRAPHY IN DIAGNOSIS OF CHRONIC DIFFUSE LI...
ROLE OF ECHOGRAPHY AND COMPUTED TOMOGRAPHY IN DIAGNOSIS OF CHRONIC DIFFUSE LI...
pbij
 
m rcc optimal sequencing agents
m  rcc optimal sequencing agentsm  rcc optimal sequencing agents
m rcc optimal sequencing agents
madurai
 
Voclosporin journal club
Voclosporin journal clubVoclosporin journal club
Voclosporin journal club
Dr. Prem Mohan Jha
 
gene therapy: What worked out and why everthing is not working
gene therapy: What worked out and why everthing is not workinggene therapy: What worked out and why everthing is not working
gene therapy: What worked out and why everthing is not working
SelestineSalema1
 
Castera élastométrie:pbh du16
Castera  élastométrie:pbh du16Castera  élastométrie:pbh du16
Castera élastométrie:pbh du16
odeckmyn
 
Pharmacogenomics of HIV Therapy
Pharmacogenomics of HIV TherapyPharmacogenomics of HIV Therapy
Pharmacogenomics of HIV Therapy
UC San Diego AntiViral Research Center
 
Dialytic support-of-aki-dep-2017
Dialytic support-of-aki-dep-2017Dialytic support-of-aki-dep-2017
Dialytic support-of-aki-dep-2017
FarragBahbah
 
Ym bio sciences corppres ash2012 dec 10 12
Ym bio sciences corppres ash2012 dec 10 12Ym bio sciences corppres ash2012 dec 10 12
Ym bio sciences corppres ash2012 dec 10 12
YMBioSciences
 
YM BioSciences CorpPres ASH2012 Dec 10 12
YM BioSciences CorpPres ASH2012 Dec 10 12YM BioSciences CorpPres ASH2012 Dec 10 12
YM BioSciences CorpPres ASH2012 Dec 10 12
YMBioSciences
 
Ngal ,cystatin c versus creatinine clearence as
Ngal ,cystatin c versus creatinine clearence asNgal ,cystatin c versus creatinine clearence as
Ngal ,cystatin c versus creatinine clearence as
Moustafa Rezk
 
4-3. Risk factors for IgAN. Rosanna Coppo (eng)
4-3. Risk factors for IgAN. Rosanna Coppo (eng)4-3. Risk factors for IgAN. Rosanna Coppo (eng)
4-3. Risk factors for IgAN. Rosanna Coppo (eng)
KidneyOrgRu
 
Raccomandazioni per la valutazione preoperatoria malattie remalii
Raccomandazioni  per la valutazione preoperatoria malattie remaliiRaccomandazioni  per la valutazione preoperatoria malattie remalii
Raccomandazioni per la valutazione preoperatoria malattie remalii
Claudio Melloni
 
Empagliflozin in acute myocardial infarction.pptx
Empagliflozin in acute myocardial infarction.pptxEmpagliflozin in acute myocardial infarction.pptx
Empagliflozin in acute myocardial infarction.pptx
purraSameer
 

Similar to FGF23 levels raise significantly in female hip fracture patients with postoperative AKI (20)

Journal Club Presentation
Journal Club PresentationJournal Club Presentation
Journal Club Presentation
 
NOAC-Midyear Poster (final)
NOAC-Midyear Poster (final)NOAC-Midyear Poster (final)
NOAC-Midyear Poster (final)
 
Spark classification
Spark classificationSpark classification
Spark classification
 
09 Nouri Acute Renal Failure
09 Nouri   Acute Renal Failure09 Nouri   Acute Renal Failure
09 Nouri Acute Renal Failure
 
09 Nouri Acute Renal Failure
09 Nouri   Acute Renal Failure09 Nouri   Acute Renal Failure
09 Nouri Acute Renal Failure
 
Utilizing Doppler Flow to Investigate the Hemodynamic Effects of Anti-Cancer ...
Utilizing Doppler Flow to Investigate the Hemodynamic Effects of Anti-Cancer ...Utilizing Doppler Flow to Investigate the Hemodynamic Effects of Anti-Cancer ...
Utilizing Doppler Flow to Investigate the Hemodynamic Effects of Anti-Cancer ...
 
CRRT Principles (Thai).pdf
CRRT Principles (Thai).pdfCRRT Principles (Thai).pdf
CRRT Principles (Thai).pdf
 
ROLE OF ECHOGRAPHY AND COMPUTED TOMOGRAPHY IN DIAGNOSIS OF CHRONIC DIFFUSE LI...
ROLE OF ECHOGRAPHY AND COMPUTED TOMOGRAPHY IN DIAGNOSIS OF CHRONIC DIFFUSE LI...ROLE OF ECHOGRAPHY AND COMPUTED TOMOGRAPHY IN DIAGNOSIS OF CHRONIC DIFFUSE LI...
ROLE OF ECHOGRAPHY AND COMPUTED TOMOGRAPHY IN DIAGNOSIS OF CHRONIC DIFFUSE LI...
 
m rcc optimal sequencing agents
m  rcc optimal sequencing agentsm  rcc optimal sequencing agents
m rcc optimal sequencing agents
 
Voclosporin journal club
Voclosporin journal clubVoclosporin journal club
Voclosporin journal club
 
gene therapy: What worked out and why everthing is not working
gene therapy: What worked out and why everthing is not workinggene therapy: What worked out and why everthing is not working
gene therapy: What worked out and why everthing is not working
 
Castera élastométrie:pbh du16
Castera  élastométrie:pbh du16Castera  élastométrie:pbh du16
Castera élastométrie:pbh du16
 
Pharmacogenomics of HIV Therapy
Pharmacogenomics of HIV TherapyPharmacogenomics of HIV Therapy
Pharmacogenomics of HIV Therapy
 
Dialytic support-of-aki-dep-2017
Dialytic support-of-aki-dep-2017Dialytic support-of-aki-dep-2017
Dialytic support-of-aki-dep-2017
 
Ym bio sciences corppres ash2012 dec 10 12
Ym bio sciences corppres ash2012 dec 10 12Ym bio sciences corppres ash2012 dec 10 12
Ym bio sciences corppres ash2012 dec 10 12
 
YM BioSciences CorpPres ASH2012 Dec 10 12
YM BioSciences CorpPres ASH2012 Dec 10 12YM BioSciences CorpPres ASH2012 Dec 10 12
YM BioSciences CorpPres ASH2012 Dec 10 12
 
Ngal ,cystatin c versus creatinine clearence as
Ngal ,cystatin c versus creatinine clearence asNgal ,cystatin c versus creatinine clearence as
Ngal ,cystatin c versus creatinine clearence as
 
4-3. Risk factors for IgAN. Rosanna Coppo (eng)
4-3. Risk factors for IgAN. Rosanna Coppo (eng)4-3. Risk factors for IgAN. Rosanna Coppo (eng)
4-3. Risk factors for IgAN. Rosanna Coppo (eng)
 
Raccomandazioni per la valutazione preoperatoria malattie remalii
Raccomandazioni  per la valutazione preoperatoria malattie remaliiRaccomandazioni  per la valutazione preoperatoria malattie remalii
Raccomandazioni per la valutazione preoperatoria malattie remalii
 
Empagliflozin in acute myocardial infarction.pptx
Empagliflozin in acute myocardial infarction.pptxEmpagliflozin in acute myocardial infarction.pptx
Empagliflozin in acute myocardial infarction.pptx
 

More from Sanja Sakan

Safety and efficacy of IgM-enriched intravenous immunoglobulins as adjunctive...
Safety and efficacy of IgM-enriched intravenous immunoglobulins as adjunctive...Safety and efficacy of IgM-enriched intravenous immunoglobulins as adjunctive...
Safety and efficacy of IgM-enriched intravenous immunoglobulins as adjunctive...
Sanja Sakan
 
Antibiotic stewardship program in clinical practice
Antibiotic stewardship program in clinical practiceAntibiotic stewardship program in clinical practice
Antibiotic stewardship program in clinical practice
Sanja Sakan
 
Neurologic complications of cardiac surgery
Neurologic complications of cardiac surgeryNeurologic complications of cardiac surgery
Neurologic complications of cardiac surgery
Sanja Sakan
 
Neurološke komplikacije kardijalne kirurgije
Neurološke komplikacije kardijalne kirurgijeNeurološke komplikacije kardijalne kirurgije
Neurološke komplikacije kardijalne kirurgije
Sanja Sakan
 
Postoperative FGF23 is an early biomarker of AKI development and AKI severit...
Postoperative FGF23 is an early biomarker of AKI development and  AKI severit...Postoperative FGF23 is an early biomarker of AKI development and  AKI severit...
Postoperative FGF23 is an early biomarker of AKI development and AKI severit...
Sanja Sakan
 
NADOKNADA KRVNIH DERIVATA TIJEKOM OPERACIJE KOD BOLESNIKA S POLITRAUMOM – p...
NADOKNADA KRVNIH DERIVATA TIJEKOM OPERACIJE KOD BOLESNIKA S POLITRAUMOM   – p...NADOKNADA KRVNIH DERIVATA TIJEKOM OPERACIJE KOD BOLESNIKA S POLITRAUMOM   – p...
NADOKNADA KRVNIH DERIVATA TIJEKOM OPERACIJE KOD BOLESNIKA S POLITRAUMOM – p...
Sanja Sakan
 
Promjena tjelesne temperature tijekom velikih intraabdominalnih operacija
Promjena tjelesne temperature tijekom velikih intraabdominalnih operacijaPromjena tjelesne temperature tijekom velikih intraabdominalnih operacija
Promjena tjelesne temperature tijekom velikih intraabdominalnih operacija
Sanja Sakan
 
KOLIKO ZAISTA KOŠTA LIJEČENJE TEŠKIH BOLESNIKA U OPĆOJ KIRURŠKOJ JEDINICI INT...
KOLIKO ZAISTA KOŠTA LIJEČENJE TEŠKIH BOLESNIKA U OPĆOJ KIRURŠKOJ JEDINICI INT...KOLIKO ZAISTA KOŠTA LIJEČENJE TEŠKIH BOLESNIKA U OPĆOJ KIRURŠKOJ JEDINICI INT...
KOLIKO ZAISTA KOŠTA LIJEČENJE TEŠKIH BOLESNIKA U OPĆOJ KIRURŠKOJ JEDINICI INT...
Sanja Sakan
 
Korist Kirurškog Apgar skora kod bolesnika sa frakturom kuka- prikaz rezultat...
Korist Kirurškog Apgar skora kod bolesnika sa frakturom kuka- prikaz rezultat...Korist Kirurškog Apgar skora kod bolesnika sa frakturom kuka- prikaz rezultat...
Korist Kirurškog Apgar skora kod bolesnika sa frakturom kuka- prikaz rezultat...
Sanja Sakan
 
Ozljeda kralježnične moždine bez radiološki vidljivog oštećenja ( Spinal Cord...
Ozljeda kralježnične moždine bez radiološki vidljivog oštećenja ( Spinal Cord...Ozljeda kralježnične moždine bez radiološki vidljivog oštećenja ( Spinal Cord...
Ozljeda kralježnične moždine bez radiološki vidljivog oštećenja ( Spinal Cord...
Sanja Sakan
 
Acute renal failure in a patient after frontotemporal craniotomy due to anest...
Acute renal failure in a patient after frontotemporal craniotomy due to anest...Acute renal failure in a patient after frontotemporal craniotomy due to anest...
Acute renal failure in a patient after frontotemporal craniotomy due to anest...
Sanja Sakan
 
Postoperative cadaveric kidney transplantation spontaneous pneumomediastinum ...
Postoperative cadaveric kidney transplantation spontaneous pneumomediastinum ...Postoperative cadaveric kidney transplantation spontaneous pneumomediastinum ...
Postoperative cadaveric kidney transplantation spontaneous pneumomediastinum ...
Sanja Sakan
 

More from Sanja Sakan (12)

Safety and efficacy of IgM-enriched intravenous immunoglobulins as adjunctive...
Safety and efficacy of IgM-enriched intravenous immunoglobulins as adjunctive...Safety and efficacy of IgM-enriched intravenous immunoglobulins as adjunctive...
Safety and efficacy of IgM-enriched intravenous immunoglobulins as adjunctive...
 
Antibiotic stewardship program in clinical practice
Antibiotic stewardship program in clinical practiceAntibiotic stewardship program in clinical practice
Antibiotic stewardship program in clinical practice
 
Neurologic complications of cardiac surgery
Neurologic complications of cardiac surgeryNeurologic complications of cardiac surgery
Neurologic complications of cardiac surgery
 
Neurološke komplikacije kardijalne kirurgije
Neurološke komplikacije kardijalne kirurgijeNeurološke komplikacije kardijalne kirurgije
Neurološke komplikacije kardijalne kirurgije
 
Postoperative FGF23 is an early biomarker of AKI development and AKI severit...
Postoperative FGF23 is an early biomarker of AKI development and  AKI severit...Postoperative FGF23 is an early biomarker of AKI development and  AKI severit...
Postoperative FGF23 is an early biomarker of AKI development and AKI severit...
 
NADOKNADA KRVNIH DERIVATA TIJEKOM OPERACIJE KOD BOLESNIKA S POLITRAUMOM – p...
NADOKNADA KRVNIH DERIVATA TIJEKOM OPERACIJE KOD BOLESNIKA S POLITRAUMOM   – p...NADOKNADA KRVNIH DERIVATA TIJEKOM OPERACIJE KOD BOLESNIKA S POLITRAUMOM   – p...
NADOKNADA KRVNIH DERIVATA TIJEKOM OPERACIJE KOD BOLESNIKA S POLITRAUMOM – p...
 
Promjena tjelesne temperature tijekom velikih intraabdominalnih operacija
Promjena tjelesne temperature tijekom velikih intraabdominalnih operacijaPromjena tjelesne temperature tijekom velikih intraabdominalnih operacija
Promjena tjelesne temperature tijekom velikih intraabdominalnih operacija
 
KOLIKO ZAISTA KOŠTA LIJEČENJE TEŠKIH BOLESNIKA U OPĆOJ KIRURŠKOJ JEDINICI INT...
KOLIKO ZAISTA KOŠTA LIJEČENJE TEŠKIH BOLESNIKA U OPĆOJ KIRURŠKOJ JEDINICI INT...KOLIKO ZAISTA KOŠTA LIJEČENJE TEŠKIH BOLESNIKA U OPĆOJ KIRURŠKOJ JEDINICI INT...
KOLIKO ZAISTA KOŠTA LIJEČENJE TEŠKIH BOLESNIKA U OPĆOJ KIRURŠKOJ JEDINICI INT...
 
Korist Kirurškog Apgar skora kod bolesnika sa frakturom kuka- prikaz rezultat...
Korist Kirurškog Apgar skora kod bolesnika sa frakturom kuka- prikaz rezultat...Korist Kirurškog Apgar skora kod bolesnika sa frakturom kuka- prikaz rezultat...
Korist Kirurškog Apgar skora kod bolesnika sa frakturom kuka- prikaz rezultat...
 
Ozljeda kralježnične moždine bez radiološki vidljivog oštećenja ( Spinal Cord...
Ozljeda kralježnične moždine bez radiološki vidljivog oštećenja ( Spinal Cord...Ozljeda kralježnične moždine bez radiološki vidljivog oštećenja ( Spinal Cord...
Ozljeda kralježnične moždine bez radiološki vidljivog oštećenja ( Spinal Cord...
 
Acute renal failure in a patient after frontotemporal craniotomy due to anest...
Acute renal failure in a patient after frontotemporal craniotomy due to anest...Acute renal failure in a patient after frontotemporal craniotomy due to anest...
Acute renal failure in a patient after frontotemporal craniotomy due to anest...
 
Postoperative cadaveric kidney transplantation spontaneous pneumomediastinum ...
Postoperative cadaveric kidney transplantation spontaneous pneumomediastinum ...Postoperative cadaveric kidney transplantation spontaneous pneumomediastinum ...
Postoperative cadaveric kidney transplantation spontaneous pneumomediastinum ...
 

Recently uploaded

Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
Donc Test
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 

Recently uploaded (20)

Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 

FGF23 levels raise significantly in female hip fracture patients with postoperative AKI

  • 1. FGF23 LEVELS RAISE SIGNIFICANTLY IN FEMALE HIP FRACTURE PATIENTS WITH POSTOPERATIVE AKI Sakan S, Bandic Pavlovic D, Basic-Jukic N, Kes P, Magas Vadlja J, Tonkovic D Department of Anesthesiology and Intensive care, Jordanovac Clinical Department of Thoracic surgery, Zagreb University Hospital Center,Jordanovac 104, Zagreb, Croatia 1.Goebel et al. J Orthop Res 2009; 27:1141-1146; Christov et al. Kidney International 2013; 84:776-785. Wang WJ et al. J Bone Miner Res 2104; 29.676-684 References Postoperative AKI -commom complication in hip fracture surgery -female geneder independent predictor -AKI incidence varies between 9% and 24% - associated with higher postoperative morbidity, mortality, longer hospital stay and treatment costs -FGF23 novel, early, renal biomarker of AKI HYPOTHESIS FGF23 is a novel, early renal biomarker of postoperative AKI in female hip fracture patients A pilot prospective cohort study during one month period Inclusion criteria: female gender, trauma hip fracture surgery, semi-scheduled surgery, age >18 years Study included two groups: 1) AKI group N=9 - female subjects who developed AKI 24 h after operation according to RIFLE/AKIN criteria 2) Control group N=7 - female subjects with normal renal function 24h after operation STUDY PROTOCOL AKI group- plasma FGF23, serum creatinine, phosphate i calcium measurements 24h after operation Control group- plasma FGF23 and serum creatinine measurement 24h after operation Introduction1 Methods2 Results3 AKI group FGF 23 levels were 39 times higher than control group (2352 vs 61 RU/ml). Hypocalcemia (median (IQR) 1,9 (1,70-2,01) mmol/l) and normophosphatemia (median (IQR) 0,89 (0,56-1,51) mmol/l) were recorded in the AKI group. Serum creatinine showed the same pattern of changes as FGF23 but not such large increase ( 354 vs 67 μmol/l) 4 Conclusion Female AKI group Control group N 9 7 Age* 80 (75-82) 75 (68-79) Baseline serum creatinine μmol/l* 78 (70-82) 99 (82-107) 0 200 400 600 800 AKI group Control group FGF23 FGF23 0 50 100 150 200 AKI group Control group Creatinine Creatinine Postoperative FGF23 levels showed significantly high and rapid elevation in AKI female hip fracture group. Female AKI group Control group Sepsis 1 0 Length of the ICU stay (days) 6 (1,5-20) 2 (2-3) Length of post ICU stay (days) 9 (4-27) 10 (8-13) Hospital mortality 1 0 Postoperative complications 1 0 Table 1 Figure 1 Figure 2 Figure 3 Table 2 0 1 2 3 Arterial hypertension Diabetes mellitus Cardiovascular Pulmonary N N *Median (IQR) *Median (IQR) 39x 5.3x